Lead Product(s): Undisclosed
Therapeutic Area: Oncology Product Name: Undisclosed
Highest Development Status: Undisclosed Product Type: Small molecule
Partner/Sponsor/Collaborator: Alta Partners
Deal Size: $50.0 million Upfront Cash: Undisclosed
Deal Type: Series A Financing January 10, 2020
Financing will used to discover and develop new small molecule therapies targeting acquired resistance in oncology.